Northwest & Ethical Investments’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,918
Closed -$181K 509
2023
Q4
$181K Sell
22,918
-24,671
-52% -$179K 0.01% 358
2023
Q3
$319K Buy
+47,589
New +$390K 0.01% 346
2021
Q3
Sell
-3,826
Closed -$27.4K 430
2021
Q2
$27.4K Buy
3,826
+2,531
+195% +$21.9K ﹤0.01% 402
2021
Q1
$13.2K Buy
1,295
+13
+1% +$122 ﹤0.01% 407
2020
Q4
$10K Buy
+1,282
New +$11.3K ﹤0.01% 405

Other funds holding VMD

Northwest & Ethical Investments's VMD Position: Q1 2024 in Review

Northwest & Ethical Investments sold out of Viemed Healthcare (VMD) in Q1 2024, closing a stake of 22,918 shares — an estimated $181K sold.

Northwest & Ethical Investments first reported a position in VMD in Q4 2020 and held it in 5 quarters. The position peaked at $319K in Q3 2023. 112 funds tracked by Wall St. Rank hold VMD as of Q1 2024.

  • Northwest & Ethical Investments reported no remaining Viemed Healthcare position as of Q1 2024 after selling out during the quarter.
  • Northwest & Ethical Investments sold 22,918 Viemed Healthcare shares in Q1 2024, an estimated $181K.
  • Northwest & Ethical Investments first reported a position in Viemed Healthcare in Q4 2020 and held it in 5 quarters.
  • Northwest & Ethical Investments's Viemed Healthcare position peaked at $319K in Q3 2023.
  • 112 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2024.

Based on Northwest & Ethical Investments's 13F filing for Q1 2024, filed 9 Jul 2025.